Vaccine to prevent Influenza Virus and Bacterial super-infection. [ 1/1/2021 - 12/31/2024 ]

Research Grant

Brief description Influenza viruses have the ability to pre-dispose infected hosts toward secondary bacterial complications. The mortality of viral infections that are complicated by a concurrent, or subsequent, bacterial infection (known as a super-infection), is often greater than that of either the virus or the bacteria alone. We will develop a novel multi-pathogen vaccine candidate against the major upper respiratory tract pathogens - Influenza A and Streptococcus pyogenes to prevent super-infections.

Funding Amount $707,717

Funding Scheme Ideas Grants

Chief Investigator Dr Mehfuz Zaman

Notes Ideas Grants